RNAC   $8.21  0.61% Market Open

Cartesian Therapeutics, Inc.
Total Cash 87.23M
totalCashPerShare 4.079
EBITDA -35.35M
Total Debt 14.87M
quickRatio 4.7
currentRatio 4.778
Total Revenue 54.10M
debtToEquity
Revenue/Share 6.64
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -62.86M
earningsGrowth
revenueGrowth 5.372
grossMargins 0.04935
ebitdaMargins -0.65336
operatingMargins 0.41132998
profitMargins 0.0
enterpriseValue 348.45M
forwardPE -5.192612
floatShares 7.25M
sharesOutstanding 23.90M
sharesShort 1.94M
sharesShortPriorMonth 2.05M
dateShortInterest
sharesPercentSharesOut 0.08%
heldPercentInsiders 0.62%
heldPercentInstitutions 0.24%
Short Ratio help_outline 15.36%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue -5.695
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -267.20M
trailingEps -47.22%
forwardEps -3.79%
enterpriseToEbitda -9.86
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.79 3Q 2024
institutionsCount 85
lastUpdated Nov. 2, 2024, 6:53 a.m.